Hot Features
Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
| Datum | Name des Inhabers | Gehandelte Aktien | Wertspanne ($) | Transaktionstyp | Preisspanne ($) | Aktien am Meldungsende | % Veränderung |
|---|---|---|---|---|---|---|---|
| 2026-05-26 | Dr. Khurram JamilChief Medical Officer | -568,00 | 1,06k | Derivative Exercise and Sale | 1,23 - 3,10 | 0,00 | - |
| 2026-02-06 | Mr. Kary EldredIndependent Director | 300,00 | 810,00 | Kauf | 2,70 | 501,63k | 0,06% |
| 2026-01-05 | Mr. Joel LewisPresident & CEO | -56,33k | 218,57k | Sale to Issuer | 3,88 | 778,26k | -6,75% |
| 2026-01-02 | Mr. Joel LewisPresident & CEO | -84,00k | 321,13k | Derivative Exercise and Sale | 3,58 - 4,20 | 834,59k | - |
| 2026-01-02 | Dr. Khurram JamilChief Medical Officer | -60,00k | 232,40k | Derivative Exercise and Sale | 3,65 - 4,20 | 0,00 | - |
| 2026-01-02 | Mr. Jack W. CallicuttCFO, Treasurer & Corporate Secretary | -60,00k | 233,39k | Derivative Exercise and Sale | 3,67 - 4,20 | 7,61k | - |
| 2025-12-31 | Dr. Khurram JamilChief Medical Officer | -8,13k | 23,10k | Derivative Exercise and Sale | 1,23 - 4,07 | 0,00 | - |
| 2025-12-23 | Mr. Kevin D. FreemanIndependent Vice Chair of the Board | 5,50k | 19,51k | Kauf | 3,55 | 153,33k | 3,72% |
| 2025-12-23 | Mr. Kary EldredIndependent Director | 700,00 | 2,61k | Kauf | 3,73 | 501,33k | 0,14% |
| 2025-12-17 | Mr. Joel LewisPresident & CEO | -7,83k | 32,85k | Derivative Exercise and Sale | 2,86 - 7,06 | 834,59k | - |
| 2025-12-17 | Dr. Khurram JamilChief Medical Officer | -14,96k | 69,87k | Derivative Exercise and Sale | 2,20 - 7,04 | 0,00 | - |
| 2025-12-17 | Dr. Khurram JamilChief Medical Officer | -4,48k | 31,53k | Automatic Disposition | 7,04 | 0,00 | -100,00% |
| 2025-12-17 | Dr. Harold H. ShlevinDirector | -20,00k | 101,16k | Derivative Exercise and Sale | 1,98 - 7,04 | 6,50k | - |
| 2025-12-17 | Dr. Harold H. ShlevinDirector | -4,50k | 31,66k | Automatic Disposition | 7,04 | 6,50k | -40,90% |
| 2025-12-16 | 10x Capital Management, LLCUnternehmen | -30,68k | 204,34k | Verkauf | 6,66 | 5,61M | -0,54% |
| 2025-11-24 | 10x Capital Management, LLCUnternehmen | -24,00k | 0,00 | Other Disposition | - | 5,61M | -0,43% |
| 2025-12-12 | Dr. Harold H. ShlevinDirector | -28,21k | 59,85k | Derivative Exercise and Sale | 4,16 - 6,30 | 11,21k | - |
| 2025-12-08 | Dr. Harold H. ShlevinDirector | -171,79k | 640,49k | Derivative Exercise and Sale | 1,11 - 6,27 | 11,21k | - |
| 2025-12-08 | Dr. Harold H. ShlevinDirector | -4,00k | 24,02k | Automatic Disposition | 6,01 | 11,21k | -26,31% |
| 2025-12-02 | 10x Capital Management, LLCUnternehmen | -162,07k | 920,86k | Verkauf | 5,47 - 5,73 | 5,67M | -2,78% |
| 2025-11-17 | Mr. Jack W. CallicuttCFO, Treasurer & Corporate Secretary | -77,92k | 359,29k | Derivative Exercise and Sale | 1,11 - 6,22 | 7,61k | - |
| 2025-11-17 | Mr. Joel LewisPresident & CEO | -22,46k | 82,68k | Derivative Exercise and Sale | 2,39 - 6,15 | 834,59k | - |
| 2025-11-13 | Dr. Khurram JamilChief Medical Officer | -99,25k | 327,86k | Derivative Exercise and Sale | 1,23 - 5,47 | 4,48k | - |
| 2025-11-13 | Dr. Khurram JamilChief Medical Officer | -21,87k | 119,61k | Automatic Disposition | 5,47 | 4,48k | -83,00% |
| 2025-11-11 | 10x Capital Management, LLCUnternehmen | -40,00k | 210,00k | Verkauf | 5,25 | 5,83M | -0,68% |
| 2025-11-10 | Mr. Joel LewisPresident & CEO | -1,87k | 6,79k | Derivative Exercise and Sale | 2,39 - 6,03 | 834,59k | - |
| 2025-11-05 | Mr. Joel LewisPresident & CEO | -200,00 | 722,00 | Derivative Exercise and Sale | 2,39 - 6,00 | 834,59k | - |
| 2025-11-03 | Mr. Joel LewisPresident & CEO | -15,72k | 57,77k | Derivative Exercise and Sale | 2,39 - 6,07 | 834,59k | - |
| 2025-10-22 | 10x Capital Management, LLCUnternehmen | -50,00k | 246,80k | Verkauf | 4,93 - 4,94 | 5,87M | -0,84% |
| 2024-04-22 | 10x Capital Management, LLCUnternehmen | -25,00k | 76,50k | Verkauf | 3,06 | 5,92M | -0,42% |
| 2025-09-12 | Mr. Joel LewisPresident & CEO | -14,00k | 55,59k | Derivative Exercise and Sale | 2,39 - 6,36 | 834,59k | - |
| 2025-09-12 | Mr. Jack W. CallicuttCFO, Treasurer & Corporate Secretary | -8,71k | 44,13k | Derivative Exercise and Sale | 1,37 - 6,44 | 7,61k | - |
| 2025-07-21 | Mr. Kary EldredIndependent Director | 1.000,00 | 2,93k | Kauf | 2,93 | 500,63k | 0,20% |
| 2025-07-17 | Mr. Kevin D. FreemanIndependent Vice Chair of the Board | 5,00k | 14,50k | Kauf | 2,90 | 147,83k | 3,50% |
| 2025-06-06 | Mr. James C. CzirrInsider | 323,13k | 699,34k | Derivative Exercise and Retained Stock | 0,89 - 4,72 | 1,05M | 44,73% |
| 2025-02-03 | Mr. James C. CzirrInsider | -20,00k | 0,00 | Other Disposition | - | 1,05M | -1,88% |
| 2024-05-10 | Mr. James C. CzirrInsider | -23,20k | 0,00 | Other Disposition | - | 741,42k | -3,03% |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Mit E-Mail registrieren
Haben Sie schon ein Konto? Anmelden
Haben Sie kein Konto? Registrieren
Durch die Registrierung bestätige ich, dass ich die Allgemeinen Geschäftsbedingungen von ADVFN gelesen und verstanden habe und ihnen zustimme und dass ich ein Privatinvestor bin.
Premium
